3/12
04:57 pm
obio
Orchestra BioMed (OBIO) had its "buy" rating reaffirmed by Chardan Capital. They now have a $20.00 price target on the stock.
Medium
Report
Orchestra BioMed (OBIO) had its "buy" rating reaffirmed by Chardan Capital. They now have a $20.00 price target on the stock.
3/12
08:38 am
obio
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update [Yahoo! Finance]
Medium
Report
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update [Yahoo! Finance]
3/12
08:17 am
obio
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Medium
Report
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
3/3
08:00 am
obio
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
Low
Report
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
2/19
08:00 am
obio
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
Low
Report
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
2/13
04:05 pm
obio
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/22
06:43 am
obio
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest shareholders are retail investors with 41% ownership, institutions own 17% [Yahoo! Finance]
Low
Report
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest shareholders are retail investors with 41% ownership, institutions own 17% [Yahoo! Finance]
1/12
09:00 am
obio
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
Medium
Report
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
3/12
08:04 am
obio
Form 10-K Orchestra BioMed Holding For: Dec 31
Medium
Report
Form 10-K Orchestra BioMed Holding For: Dec 31
2/27
04:11 pm
obio
Form SCHEDULE 13G/A Orchestra BioMed Holding Filed by: Medtronic plc
Neutral
Report
Form SCHEDULE 13G/A Orchestra BioMed Holding Filed by: Medtronic plc
2/25
04:29 pm
obio
Form SCHEDULE 13D/A Orchestra BioMed Holding Filed by: RTW INVESTMENTS, LP
Low
Report
Form SCHEDULE 13D/A Orchestra BioMed Holding Filed by: RTW INVESTMENTS, LP
2/13
05:02 pm
obio
Form 4 Orchestra BioMed Holding For: Feb 12 Filed by: Sherman Darren
Low
Report
Form 4 Orchestra BioMed Holding For: Feb 12 Filed by: Sherman Darren
2/13
05:02 pm
obio
Form 4 Orchestra BioMed Holding For: Feb 12 Filed by: Aiello Joshua
Low
Report
Form 4 Orchestra BioMed Holding For: Feb 12 Filed by: Aiello Joshua
2/13
05:01 pm
obio
Form 4 Orchestra BioMed Holding For: Feb 12 Filed by: Taylor Andrew Lawrence
Low
Report
Form 4 Orchestra BioMed Holding For: Feb 12 Filed by: Taylor Andrew Lawrence
2/13
05:01 pm
obio
Form 4 Orchestra BioMed Holding For: Feb 12 Filed by: Hochman David P
Low
Report
Form 4 Orchestra BioMed Holding For: Feb 12 Filed by: Hochman David P
2/13
05:01 pm
obio
Form 8-K Orchestra BioMed Holding For: Feb 12
Low
Report
Form 8-K Orchestra BioMed Holding For: Feb 12
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register